Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Criteria for deciding cost-effectiveness for expensive new anti-cancer agents.

× No keyword cloud information.

6 in total

Review 1. Advances in cancer therapeutics and patient access to new drugs.

Authors: George Dranitsaris; Ilse Truter; Martie S Lubbe; Eitan Amir; William Evans
Journal: Pharmacoeconomics Date: 2011-03 Impact factor: 4.981

Review 2. Health economics and cost-effectiveness research with special reference to hemato-oncology.

Authors: Rajat Kumar
Journal: Med J Armed Forces India Date: 2013-07-22

Review 3. The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials.

Authors: Jacopo Giuliani; Andrea Bonetti
Journal: J Gastrointest Cancer Date: 2016-12

4. Cost effectiveness of telecare management for pain and depression in patients with cancer: results from a randomized trial.

Authors: Sung J Choi Yoo; John A Nyman; Andrea L Cheville; Kurt Kroenke
Journal: Gen Hosp Psychiatry Date: 2014-07-19 Impact factor: 3.238

5. Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria.

Authors: George Dranitsaris; Lesley G Shane; Jean-Philippe Galanaud; Gunar Stemer; Philippe Debourdeau; Seth Woodruff
Journal: Support Care Cancer Date: 2017-02-15 Impact factor: 3.603

6. Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.

Authors: George Dranitsaris; Lesley G Shane; Seth Woodruff
Journal: J Oncol Pharm Pract Date: 2017-08-31 Impact factor: 1.809

6 in total